Project Grant R21HD112011
Award Date
8/8/24
Completion Date
7/31/26
Dollars Obligated
$220K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Reno, NV 89557, USA
Similar Awards
This Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to Vanderbilt University provides $126,568 to support the development of a novel, uterine-targeted drug delivery system to treat preterm labor. The key objectives are to: 1) optimize the physical-chemical parameters and antibody targeting for the drug delivery system, and 2) evaluate the in vivo efficacy and side-effect mitigation of...
This $248,999 federal Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to identify effective therapeutic agents for managing infection-induced preterm labor (III-PTL). The primary objectives are to: 1) Optimize a high-throughput screening assay to measure changes in proinflammatory cytokines released from pathogen-associated molecular...
This $2,060,562 federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to develop a novel therapeutic approach for preventing preterm labor and fetal inflammation. The grant recipient, the University of California, Los Angeles (UCLA), will investigate the use of a synthetic progestin compound (R5020) that is resistant to inactivation, with the...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is focused on developing and testing an innovative approach to reduce inflammation-associated preterm birth. The $635,254 award to the University of Texas Medical Branch at Galveston will fund research to evaluate the safety, stability, and efficacy of extracellular vesicle-mediated delivery of the...
This federal Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports the development and testing of water-soluble prodrugs of the compound AKT-1005 for the treatment of preeclampsia. The $262,808 award to Beth Israel Deaconess Medical Center, Inc. (Bidmc) will fund the synthesis, screening, and in vitro/in vivo evaluation of these prodrugs to improve...
This Project Grant award from the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development provides $769,916 to Emergent Biotechnologies LLC for research into a novel therapy for preeclampsia. The funding supports Phase 1 of developing and characterizing a handle region peptide as an innovative treatment for preeclampsia under the Child Health and Human Development Extramural Research program (CFDA 93.865). Phase 1 work will...
The University of Memphis received a $138,455 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop an animal model to test HDAC6 as a drug target to reduce and/or prevent fetal growth restriction (FGR). The award will fund research to genetically delete HDAC6 from MAP3K4 knockout mice to assess whether this improves fetal and placental growth and survival,...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $235,803 to Texas A&M Engineering Experiment Station (Tees) to bioengineer a 3D human myometrium model. The goal is to directly evaluate the kinetics of uterine smooth muscle contractility in response to varying doses of oxytocin, a critical mechanism for successful labor and delivery. By combining...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $234,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to conduct research on a novel NF-kB genetic variant associated with preeclampsia, a serious pregnancy complication. The key objectives are to: Establish if the NF-kB variant is linked...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $485,925 to the University of Massachusetts Boston to develop novel antioxidant compounds for treating preeclampsia, a life-threatening pregnancy complication. The primary goal is to design and synthesize cationic hydrazone antioxidants that can target mitochondria to reduce oxidative stress, improve...